Delivery of potentially therapeutic drugs to the brain is hindered by the blood-brain barrier (BBB), which restricts the diffusion of drugs from the vasculature to the brain parenchyma. One means of overcoming the BBB is with cellular implants that produce and deliver therapeutic molecules. Polymer encapsulation, or immunoisolation, provides a means of overcoming the BBB to deliver therapeutic molecules directly into the CNS region of interest. Immunoisolation is based on the observation that xenogeneic cells can be protected from host rejection by encapsulating, or surrounding, them within an immunoisolatory, semipermeable membrane. Cells can be enclosed within a selective, semipermeable membrane barrier that admits oxygen and required nutrients and releases bioactive cell secretions, but restricts passage of larger cytotoxic agents from the host immune defense system. The selective membrane eliminates the need for chronic immunosuppression of the host and allows the implanted cells to be obtained from nonhuman sources. In this review, cell immunoisolation for treating CNS diseases is updated from considerations of device configurations, membrane manufacturing and characterization in preclinical models of Alzheimer's and Huntington's disease.
INTRODUCTION
tides, and other compounds with enormous treatment potential. The majority of these compounds are, how-Progressive central nervous system (CNS) diseases ever, not active following systemic administration, in are characterized by the continuous deterioration of both large part because the brain uses the blood-brain barrier cognitive and motor functions leading to prolonged peri-(BBB) to modulate the local and global exchange beods of increasing incapacity. Among the most problemtween the vasculature and brain parenchyma. The BBB atic and prevalent neurological disorders are those assoprovides an exquisite regulation of the internal chemical ciated with the loss of specific populations of brain environment of the CNS by regulating the internal envineurons. Today, approximately 12 million people in the ronment with a mechanism of low passive permeability United States suffer from such neurological disorders.
combined with a highly selective transport system be-Estimated costs in the United States of public expenditween the blood and the brain (20, 81) . It has also been tures and secondary medical expenses for treating paa source of frustration for researchers and clinicians tients with neurological disorders exceed $400 billion searching for a means of introducing drugs to the brain. annually (82) . Expenses directly attributed to the organic One means of overcoming the BBB is with cellular neurological disease are estimated to account for 25% of implants that produce and deliver therapeutic molecules that amount. Beyond monetary costs to the health care directly into the CNS region of interest. In recent years, economy, however, the medical, societal, familial, and one iteration of cell-based therapy proposes to use xenopersonal costs cascading from these diseases defy calcugeneic cells that are encased within a selectively permelation.
able polymeric membrane, known as immunoisolation. Advances in genetic engineering and genomics are Immunoisolation was originally described in 1933 by making available an increasing number of proteins, pep-Bisceglie (13), who demonstrated encapsulated xeno- 4 EMERICH AND SALZBERG graft cell survival beyond the limit for humoral rejec-membrane around cellular clusters, cells can be exposed to organic solvents (25) . Other types of microcapsules tion. The further application of immunoisolation for the CNS owes much of its foundation to investigators fo-(e.g., the polyelectrolytes), although nontoxic during processing, are generally mechanically fragile and chemi-cused on peripheral diseases, particularly diabetes (21, 22, 23, 53, 68, 79) . Immunoisolation is based on the obser-cally unstable. For the polyelectrolytes, microcapsule membranes are formed by ionic or hydrogen bonds be-vation that xenogeneic cells can be protected from host rejection by encapsulating, or surrounding, them within tween two weak polyelectrolytes with opposite charges (68) . Microcapsules can be prepared by gelling droplets an immunoisolatory, semipermeable membrane. Single cells or small clusters of cells can be enclosed within a of a polyanion/cellular suspension (e.g., alginate) in a mixing divalent cationic bath, which immobilizes the selective, semipermeable membrane barrier that admits oxygen and required nutrients and releases bioactive cell cells in a negatively charged matrix, and then coating the immobilized cells with a thin film of a polycation, secretions, but restricts passage of larger cytotoxic agents from the host immune defense system. The selec-such as poly-L-lysine ( Figs. 1 and 2) . The poly-L-lysinealginate bond creates a permselective membrane whose tive membrane eliminates the need for chronic immunosuppression of the host and allows the implanted cells molecular weight cutoff is on the order of 30,000-70,000 daltons (108) . Because poly-L-lysine is not bio-to be obtained from nonhuman sources, thus avoiding the constraints associated with cell sourcing, which have compatible, a second layer of alginate is generally added to the capsule surface. Polyelectrolyte-based techniques limited the clinical application of unencapsulated cell transplantation.
have the advantage of avoiding organic solvents and, with proper permeability control, microcapsules repre-CNS DELIVERY TECHNOLOGIES sent a very effective configuration for cell viability and A number of strategies have been described to cirneurochemical diffusion. These types of microcapsules cumvent the BBB. Some of the techniques currently are, however, mechanically and chemically fragile, as available for delivering therapeutic molecules directly well as difficult to retrieve. into the brain include: 1) carrier-or receptor-mediated Macroencapsulation transcytosis (39,40); 2) osmotic opening (51, 66) ; 3) direct infusion with stereotactic guidance (60, 74, 78) ; 4) Macroencapsulation involves filling a hollow, usually osmotic pumps (75,103); 5) sustained-release polymer cylindrical, selectively permeable membrane with cells, systems (49,67,107); 6) cell replacement/cell therapy generally suspended in a matrix, and then sealing the (4, 6, 18, 29, 38, 45, 105, 112) and gene therapy (5,15,16,52, ends to form a capsule (Figs. 3 and 4) [reviewed in 114) . A presentation outlining these techniques was re-(44, 110) ]. Polymers used for macroencapsulation are bicently reviewed (91) . This review highlights site-speodurable, with a thicker wall than that found in microencific cell therapies with encapsulated, immunoisolatory capsulation. While thicker wall and larger implant diamdevices. The membrane isolates the enclosed cells from eters can enhance long-term implant stability, these the host immune system, preventing recognition of the features may also impair diffusion, compromise the viaenclosed cells as foreign, thus permitting the use of celbility of the tissue, and slow the release kinetics of delular transplants across major histocompatibility barrisired factors. In theory, macroencapsules can be reers. Encapsulated cell therapy has been studied most extrieved from the recipient and replaced if necessary. tensively for the treatment of diabetes, using insulin-Macroencapsulation is generally achieved by filling secreting cells (12, 21, 26, 50, 53, 79) , and age-related depreformed thermoplastic hollow fibers with a cell susgenerative diseases such as Parkinson's, Huntington's, pension. The hollow fiber is formed by pumping a soluand Alzheimer's disease (89) . There are generally two tion of polymer in a water-miscible solvent through a categories for cell immunoisolation by encapsulation, nozzle concurrently with an aqueous solution. The polymicro and macro, each with some benefits and limitamer solution is pumped through an outer annular region tions (Table 1) .
of the nozzle, while the aqueous solution is pumped through a central bore. Upon contact with the water, the CELL IMMUNOISOLATION polymer precipitates and forms a cylindrical hollow fi-Microencapsulation ber with a permselective inner membrane or "skin." Further precipitation of the polymer occurs as the water Microencapsulation involves surrounding cells with a thin, spherical, semipermeable polymer film (68) . The moves through the polymer wall, forcing the organic solvent out and forming a trabecular wall structure. The small size, thin wall, and spherical shape of microcapsules are structurally optimal for diffusion, cell viability, hollow fiber is collected in a large aqueous water bath, where complete precipitation of the polymer and disso-and release kinetics. However, in certain types of thermoplastic-derived processing to form the microcapsule lution of the organic solvent occurs. The ends of the A second method of macroencapsulation, called coextrusion, avoids the sealing problem by entrapping cells within the lumen of a hollow fiber during the fabrication process (3) . Pinching the fiber before complete precipitation of the polymer causes fusion of the walls, providing closure of the extremities while the cells are inside. The advantages of coextrusion over loading preformed capsules include more uniform distribution along the entire length of the fiber and reduced shear stresses on the cells during the loading process. In addition, the coextrusion process offers the potential for mass production of cell-loaded capsules.
Several modifications to macrocapsule configurations have been designed to provide added strength to ensure device integrity. It is important for the encapsulating membrane to exhibit enough compliance to meet the dynamics of the surrounding tissue, therefore not eliciting a foreign body reaction, yet mechanically resilient to resist failure during device implantation/retrieval. Me- ing membrane and the surrounding tissue. One approach als within the tubular device has provided a material compliant with the membrane that enhances the tensile includes the addition of a cross-linked hydrogel (e.g., a 2% alginate solution) within the device. This modifica-strength of the device. tion was observed to enhance structural support during CELLS AND EXTRACELLULAR MATRICES the implantation procedure (90). However, with time the USED IN ENCAPSULATION hydrogel loses structural integrity and does not provide added strength, especially with regard to tensile strength, Cells placed within encapsulation devices generally fall into one of three categories. The first category is an important consideration for device retrieval.
The ability to retrieve devices or to remove the cellu-represented by primary postmitotic cells such as islets of Langerhans for diabetes, adrenal chromaffin cells for lar contents from within are important safety considerations for potential complications such as brain edema chronic pain, or hepatocytes for liver devices. Secondly, immortalized (or dividing) cells such as PC12 cells have following implantation, contamination, dosing modifications, or patient request. Early designs were based on a been utilized to deliver dopamine for Parkinson's disease. The third category is typically cell lines that have semipermeable receptacle (107) or U-shaped configuration (2) attached to the host skull. These configurations been genetically engineered to secrete a bioactive substance such as baby hamster kidney (BHK) cells to se-offered the ability to empty and refill the devices, or retrieve the devices themselves, without disrupting the crete factors like human nerve growth factor (hNGF) for a potential therapy in Alzheimer's disease. Dividing tis-host brain with additional neurosurgical procedures. However, devices secured to the skull could exhibit me-sue has advantages over postmitotic tissue; it can be expanded, banked, and thus more easily tested for sterility chanical perturbations to the host tissue due to mechanical noncompliance and elicit an elevated foreign body and contaminants. However, dividing tissue is also constrained by the potential for overgrowth within the reaction from the host. Other configurations with internal supports have included titanium wires and braided capsule environment, resulting in an accumulation of necrotic tissue that could potentially diminish the mem-materials to provide added tensile strength during device retrieval. Devices incorporating a titanium wire could brane's permeability characteristics, further reducing cell viability and neurochemical output. be associated with mechanical noncompliance within the device, rendering the flexible membrane susceptible to In vivo, extracellular matrices (ECMs) provide control of cell function through the regulation of morphol-damage. In contrast, the incorporation of braided materi- ogy, proliferation, differentiation, migration, and metas-adrenal chromaffin cells have been immobilized in alginate to prevent aggregation, which, in turn, reduces cen-tasis (28, 73, 80) . Within a capsule, ECMs were originally employed simply to prevent aggregation of cells (immo-tral necrotic cores from forming (1) . The chromaffin cells appear to thrive in alginate whereas mitotically ac-bilization) and resultant central necrosis, but have since been found to be beneficial to the viability and function tive fibroblasts do not. In this case, the use of alginate is essential to the optimal functioning of this device be-of cells that require immobilization, as well as a scaffolding for anchorage-dependent cell lines. For example, cause some anchorage-dependent cells such as fibro- Figure 4 . Diagram illustrating the different components of a macrocapsule contributing to successful implantation and cell viability. The manufacturing process involves several different aspects each with its own complexities. The initial choice of cell types includes primary, immortalized, or engineered. Intracapsular cell biology issues following encapsulation include a consideration of the need to use a compatible extracellular matrix and other considerations specific to that cell type because they impact cell nutrition and product synthesis. A series of other device-related issues include membrane geometry, morphology, and transport of molecules into and out of the device. Finally, the device must be sealed and, depending on the site of implantation, could require a tether for subsequent retrieval or the inclusion radio-opaque markers for imaging purposes.
blasts or endothelial cells are present with the adrenal within, should be rigorously characterized to determine the optimal configuration for each cell type. chromaffin cells. In the absence of alginate or similar immobilizing matrices, the fibroblasts can expand and PREPARATION OF overgrow the encapsulated milieu, resulting in a device IMMUNOISOLATORY MEMBRANES deficient in bioactive factors produced from the chromaffin cells (97) . In contrast, BHK cells, a fibroblastic
The majority of thermoplastic ultrafiltration (UF) and microfiltration (MF) membranes used to encapsulate cell line, thrive in collagen, while PC12 cells exhibit a preference for distribution within precipitated chitosan, cells are manufactured from homogenous polymer solutions by phase inversion (19). Ultrafiltration membranes which provides a scaffolding structure on which the cells anchor (31,113). Additionally, chitosan has been have pore sizes ranging from 5 nm to 0.1 µm while microfiltration (or microporous) membranes have pores shown to be an effective substrate for the attachment and spreading of fibroblasts (113).
ranging from 0.1 to 3 µm. Phase inversion is a versatile technique that allows for the formation of membranes In order to provide a substratum designed for more specific functions, the matrix material can be manipu-with a wide variety of nominal molecular weight cutoffs, permeabilities, and morphologies. The morphology and lated chemically or mechanically, which in turn may influence cell attachment, differentiation, and/or prolif-membrane properties depend on the thermodynamic parameters and kinetics of the fabrication process. In phase eration. For example, peptides, such as arginine-glycineaspartic acid (RGD), have been immobilized on a vari-inversion, the polymer is first dissolved in an appropriate solvent. The solution is cast as a flat sheet or ex-ety of surfaces to promote cell adhesion (96). Integrin receptors on the cell surface membrane interact with truded as a hollow fiber. As part of the casting or extrusion procedure, the polymer solution is precipitated by the RGD sequence, a known ligand for fibronectin receptors. Glass microbeads have been modified by at-a phase transition, which can be brought about by changing the temperature or solution composition. This taching RGD or tyrosine-isoleucine-glycine-serine-arginine (YIGSR) motifs to provide sites for cell adhesion process involves the transfer of a single-phase liquid polymer solution into a two-phase system consisting of (71). Spherical ferromagnetic beads have been coated with specific receptor ligands to mediate cell attachment a polymer-rich phase that forms the membrane structure, and a second liquid polymer-poor phase that forms the (104). With competitive binding assays and a mechanical stress testing apparatus, the endothelial cell's interac-membrane pores. Any polymer that will form a homogenous solution, which under certain temperatures and tion with the ECM receptor, integrin beta-1, supported a force-dependent stiffening response, while nonadhesion compositions will separate into two phases, can be used. Thermodynamic and kinetic parameters, such as the receptors did not. A laminin-derived oligopeptide sequence, CDPG-YIGSR, has also been derivitized within chemical potential of the components and the free energy of mixing of the components, determine the manner an agarose hydrogel and permitted a dose-dependent increase in neurite outgrowth of neuronal cell bioassays in which the phase separation takes place (94). In cases where membrane strength limits the overall (11). Similarly, YIGSR and isoleucine-lysine-valine-alanine-valine (IKVAV), both of which are found in lami-device strength, the membrane must be manufactured with certain considerations in mind, and the membrane nin, have been immobilized on surfaces to promote neuronal cell adhesion and neurite outgrowth (96). Poly-dimensions, composition, and structure may have to be altered. Choosing a material that is inherently stronger (ethylene oxide) (PEO)-star copolymers have been fabricated as a potential synthetic extracellular matrix (24) .
(i.e., more ordered), or higher in molecular weight, with which to cast the membrane should increase the overall The star copolymers provide many hydroxyl groups where various synthetic oligopeptides can be attached to mechanical properties. UF or MF membranes can be fabricated with macrovoids within the wall or as an desired specifications.
The survival and differentiation of encapsulated cells open-cell foam where the microvoids are interconnected. By incorporating techniques that increase the isoreticu-can be influenced by the matrix interactions. A variety of matrices for use in immunoisolatory devices, such as lated structure within the membrane wall, the tensile strength can be increased with similar membrane poros-alginate, rat tail collagen extracts, gelatin shards, porous gelatin or collagen microcarriers, carrageenan, chondroi-ity, thus maintaining the same overall diffusive transport. The strength also can be improved by increasing tin sulfate, fibrin, hyaluronic acid, the positively charged substrate chitosan, and an acrylamide-based thermore-the cross-sectional area of the membrane by thickening the walls. Decreasing the overall membrane porosity in-sponsive gel are available and were recently reviewed (36). The interactions between the encapsulating mem-creases the overall membrane strength. An example of a macrovoid containing structure is presented in Figure 3 . brane characteristics and the capsule core, or matrix
The outer morphology of the membranes can be al-Fick's first law, which can be integrated assuming a homogenous membrane and a solute concentration-inde-tered during fabrication or by a posttreatment to improve the host tissue reaction. Using various phase inversion pendent diffusion coefficient (14), yielding: techniques, the outer surface of the membrane can range
from a selectively permeable membrane "skin" to a structure large enough to allow cells to enter the wall where ∆C is the bulk solution concentration difference (approximately 10-20 µm in diameter). The combinabetween the fiber lumen (l) and the bath (b) [g/cm 3 ], and tion of proper membrane transport and outer morpholok t is the overall mass transfer coefficient [cm/s]. Algies also may be achieved with composite membranes though nonlinearities in the concentration profile caused (17).
by chemical, charge, or other interactions of the solute with the membrane material may make the internal con-MEMBRANE TRANSPORT CHARACTERIZATION centration impossible to predict, they can usually be taken into account by using overall "lumped-parameter" Membrane transport is typically characterized by the mass transport coefficients. Ideally, solute concentration capability to retain marker molecules in convective sievis uniform in the liquid region on either side of the meming experiments. Here the rejection coefficient, R, is debrane and decreases linearly across the membrane. In fined as:
practice, such profiles are approximated only when the membrane resistance is large compared to the unstirred R − 1 = C f /C r (1) liquid resistances. However, even with aggressive stirring, the transport of small, rapidly diffusing solutes can where C f and C r are the concentrations of a marker in lead to gradients within the media that, if neglected, may the filtrate and retentate, respectively. cause large errors in calculated membrane mass transfer Although standard convective measurements give an coefficients. The contribution of the unstirred liquid reapproximate idea of what size molecules can pass gions, often referred to as boundary layers, may be acthrough a membrane, they are insufficient to predict the counted for by defining the reciprocal overall mass rate or selectivity in diffusion-based devices. Because transfer coefficient as an inverse sum of the coefficients immunoisolation systems are primarily diffusion based, for each region: it is essential to determine the diffusive transport properties of the membrane in order to understand the intracapsular environment of encapsulated cells, optimize the
passage of essential metabolic species and molecules of interest, and assess the degree of immune exposure.
where the subscripts b, m, and l refer to the outside bath, membrane, and fiber lumen, respectively.
General Theory
In the absence of electrochemical or buoyant effects, Small Solutes the one-dimensional flux, N[g/cm 2 s], of a dissolved sol-To minimize the effect of boundary layers, the memute, i, may be represented by the following equation:
brane diffusivity of rapidly diffusing small solutes can be measured using a flowing-type system in which sol-
ute diffuses from a recirculating bath fluid through the membrane wall and is carried away by buffer that is where D is the diffusion coefficient [cm 2 /s], C is the slowly pumped through the fiber lumen at a known flow concentration [g/cm 3 ], x is the distance [cm], σ is the rate. The mixing cup concentration of solute i, (C mc ) i , Stavermen reflection coefficient [dimensionless], and v which is equal to the flux divided by the average velocis the mass velocity per surface area [g/cm 2 s]. The conity, is measured in the collected lumen fluid. Using eq. centration-and pressure-dependent terms above repre-(3) and assuming the buffer entering the fiber lumen is sent the diffusive and convective components of solute solute free, the overall device-averaged mass transfer transport. Equation (2) can usually only be integrated coefficient can be expressed in terms of the following for special cases where the interdependence of conveceasily measured variables: tion and diffusion is known or where the two components can be assumed to be independent and additive.
(
However, in cases of no transmembrane convection (velocity, v i = 0), applicable for many immunoisolation de-where A is the log mean membrane surface area calculated for an annulus [= 2π(r 2 − r 1 )z/ln(r 2 /r 1 ), where r 2 and vices, the second term drops out, and eq. (2) becomes r 1 are the outer and inner radii, respectively, z is the was initially filled with solute-free buffer. In these cases, stirring is not required to reduce boundary layers as dif-length], and Q f is the volumetric flow rate through the fiber lumen in µl/minute. fusion through the membrane is the rate-limiting step in transport. Equating the flux N i from eq. (3) with the flux Membrane (k m ) i across the membrane the following is obtained: The transport resistance of the membrane is a complicated function of bulk diffusivity (D), membrane thick-
ness, tortuosity, equilibrium partition coefficient (which in turn is a function of porosity, pore size distribution, A mass balance equates the amount of solute leaving the and membrane/solute interactions), and reduced pore fiber to the amount entering the bath and integrating diffusivity. In most practical situations, (k m ) i is impossiyields eq. (8): ble to calculate from fundamental principles and is instead calculated from measurements of overall mass ln
Effectively, (k m ) i can be viewed as the proportionality constant that relates the measured flux, N i , to the concentration difference of solute i across the memwhere brane if the solution concentration at the membrane/solution interface is known.
where t n is time of sampling of the nth sample, (C l ) n and These effects can be separately calculated using a (C b ) n are the lumen and bath concentrations of the nth Sherwood number analysis to yield eq. (6):
sample, respectively, and V r is the replacement volume. Figure 5 shows the diffusive characterization, including
the membrane mass transfer coefficient, relative membrane diffusivity (D m /D H 2 O ), and the convective sieving where Q f is the volumetric flow rate through the fiber curve of a membrane manufactured and characterized lumen in µl/min, C b and C mc are the bath side and mixing using these principles. cup concentrations, respectively.
VALIDATION OF THE CONCEPT Large Solutes
OF IMMUNOISOLATION Large solutes are practically defined as solutes with
In Vitro Studies a molecular weight or size equal to or greater than the nominal molecular weight cutoff of the membrane Two general approaches have been used to validate the premise that encapsulated cells are indeed immunoi-(defined as the molecular weight at 90% rejection in a convective measurement). These solutes are sterically solated. The maintenance of immunoisolation (i.e., capsule integrity) has been evaluated by several methods. excluded from all but the largest pores, creating a membrane transport resistance that is at least an order of Initial integrity was characterized by encapsulating a polydisperse (10 3 -10 6 g/mol) dextran solution and moni-magnitude greater than the surrounding bath and lumen resistances. In encapsulation studies, k l and k b often ac-toring the flux of the molecules across the semipermeable membrane over time. Similar to what has been de-count for less than 10% of the membrane resistance, and their contribution to the overall resistance is assumed to scribed for assessing the molecular weight cutoff of hollow fiber membranes, a dextran rejection curve was be insignificant. Accordingly, the elaborate calculations introduced for the smaller solutes to compensate for the measured from the filtrate and reservoir concentrations measured by gel permeation chromatography (27) . With boundary layer contributions are not necessary. The large solutes used in diffusion studies are typically both controlled devices that had been damaged, the large molecular weight dextran species were observed within the proteins (bovine serum albumin, immunoglobulin-G, and apoferritin) and fluorescein-tagged dextrans (10-reservoir concentrations, while intact, integral capsules did not demonstrate these observations. In addition, cap-2000K). Because long measurement times are necessary to attain detectable quantities of these large solutes, the sule integrity has been evaluated in vitro on PC12 cellloaded macrocapsules (110) . This system tested the membrane mass transfer coefficient, (k m ) i , is usually measured in the static system, wherein a marker solution capability of the selectively permeable membrane to protect encapsulated PC12 cells against the cytotoxic was loaded inside the fiber and allowed to diffuse through the membrane into the surrounding bath, which killing of antibody (IgG)-mediated complement lysis. With integral cell-loaded capsules, in the presence of cessing agents, surface integrity and microgeometry, and the size and shape of the implant (14). The constituents antibody and complement, the capsular membrane prevented antibody-mediated complement lysis (<10% cell of the implants should be assessed rigorously, both in vitro and in vivo, to determine the safety of the materi-death), while complete killing (100%) was observed in cases of damaged capsules or with PC12 cells not encap-als. For implants into the brain, the CNS tissue is not only privileged from an immunologic standpoint, but sulated.
also lacks the primary reactive cells, fibroblasts and In Vivo Studies macrophages, found in peripheral locations. The brain, The importance of polymer capsule integrity for xetherefore, offers a unique environment in terms of the nografted PC12 cell survival is illustrated in studies inflammatory response as well as the cellular constitwhere unencapsulated PC12 cells, or cells encapsulated uents that comprise the reactive cells. Immunospecific in breached (intentionally damaged) membranes, have antibodies are available to delineate the roles of the been implanted in the brains of guinea pigs (i.e., a xenobrain reactive cells, the astrocytes and microglia, with graft) (2) . Intact PC12 cell-loaded capsules implanted respect to their reactivity. Nevertheless, few studies have into the guinea pig striatum showed no lymphocytic insystematically examined the reaction of host brain tissue filtration and a minimal astrocytic reaction by GFAP to the presence of polymeric devices. staining. In contrast, cell survival was poor in capsules Early investigations utilizing electron microscopic that were intentionally damaged, with marked inflammatechniques to characterize the brain tissue reaction to tion and heavy lymphocytic invasion into the capsule.
plastic-embedded metal electrodes and polymer implants Moreover, unencapsulated PC12 cells do not survive (14,77,93) reported in detail on the biocompatibility of a following implantation into either the guinea pig or the thermoplastic-based macrocapsule implanted into brain nonhuman primate striatum while encapsulated PC12 tissue. Necrosis of the tissue surrounding the polymer cells have demonstrated viability for 6 months in nonhucapsules implanted into the striatum of rodents was minman primates (62) .
imal, and small Nissl-positive cells were observed in-In addition, long-term studies were undertaken to vading the open trabeculae in the wall of the macrocapevaluate the ability of a rat to generate antibodies against sules. Immunospecific analysis for glial fibrillary acid bovine adrenal chromaffin cells when implanted in the protein (GFAP) indicated that reactive astrocytes were ventricular space (70) . There was no evidence of elepresent 1-2 weeks after implantation, with the intensity vated levels of rat anti-bovine adrenal chromaffin cell of this reaction diminishing with time. By 4 weeks after IgG or IgM levels in serum from rats implanted with implantation, there was a minimal gliotic reaction surencapsulated xenogeneic adrenal chromaffin cells evalurounding the polymer implant. No significant changes in ated monthly for nearly 1.5 years in vivo. In contrast, a myelin basic protein reactive oligodendroglia were obrobust host immune response was induced in all animals served, and neuron-specific enolase-reactive neurons at 5 months after implantation with unencapsulated bowere readily identifiable adjacent to the implant. Subsevine adrenal chromaffin cells.
quent studies with an immunospecific antisera against While these studies provide some level of comfort rat microglia, OX-42, revealed a reaction and time course for the immunoisolatory nature of permselective memsimilar to the astrocytes. Lastly, electron microscopic branes, very few studies using encapsulated cells actuanalysis further revealed cellular and capillary invasion ally determined whether the procedure used formed a into the trabecular networks of the polymer walls. truly immunoisolatory membrane. Conceivably, mem-
The capillary invasion provides an ample supply of branes used may have had molecular weight cutoffs sufnutrients and oxygen in proximity to the encapsulated ficiently high enough to alter the function and viability cells. However, because the process of angiogenesis for of the cells. neovascularization typically evolves in a 4-7-day period, the encapsulated cells must endure an initial period BIOCOMPATIBILITY of nutrient and oxygen deprivation. In addition, because the only means of delivery of the desired cellular prod-Transplant survival, with and without an encapsulating membrane, is mediated by many factors. The cellu-ucts from an encapsulated cell implant is by diffusion, any reaction around the capsule might diminish the dif-lar/tissue reaction generated by a host in response to a foreign body, typically referred to as biocompatibility, fusion of therapeutic products from the encapsulated cells and could compromise the viability of the encapsu-impacts the success of the transplant. Factors that affect biocompatibility can include the method of implantation lated tissue. These studies clearly demonstrated biocompatibility within the host nervous system, which sug-(48), the implant site (14), and implant properties, such as composition of the polymer, potential residual pro-gests that the bidirectional transport of low molecular weight solutes across the permselective membrane can tion from the CNS. Electron microscopy confirms the presence of numerous mitochondria, polysomes, and be maintained in vivo. However, these studies were undertaken with empty polymer macrocapsules (106) . Cells electron-dense secretory vesicles distributed within the cytoplasm. Both rodent microdialysis and positron emis-enclosed within the capsule can impact device biocompatibility. The inclusion of primary tissues, such as bo-sion tomography (PET) studies in primates have confirmed that encapsulated PC12 cells continue to produce vine adrenal chromaffin cells, typically results in a host tissue interface equivalent to that observed for the empty L-dopa/dopamine in situ (95,98). Other cell types, specifically bovine adrenal chromaffin cells, have been re-capsules. In contrast, PC12 cell-loaded capsules can elicit a more robust host response but, additionally, have in-ported to survive for prolonged periods of time following encapsulation. The long-term survival of bovine creased the level of angiogenesis adjacent to the implant. Enhancing angiogenesis has also been investigated by adrenal chromaffin cells in macrocapsules has been characterized in spinal implants to provide a sustained releasing VEGF from planar diffusion chambers to induce vascularization of the transplanted devices (99).
source of pain-reducing neuroactive substances (83). The most convincing demonstration of long-term survival of In an effort to further enhance the biocompatibility for cell line-containing implants, or reduce protein ad-chromaffin cells comes from a study in which intraventricular implants of encapsulated bovine chromaffin cell sorption that may negatively impact the ability to maintain adequate long-term diffusive characteristics, several implants survived for nearly 1.5 years and continued to produce catecholamines and met-enkephalin (70) . These postsynthesis modifications have been attempted. Poly-(acrylonitrile-co-vinyl chloride) (PAN/VC) hollow fiber results indicated the capacity for long-term survival of encapsulated xenogeneic cells implanted in the lateral membranes that were surface modified by grafting poly-(ethylene oxide) (PEO) groups exhibited improved bio-ventricles of rats. Similar observations in a higher species have not been obtained. compatibility in brain tissue over the unmodified PAN/ VC controls (88) . Similar observations were made with One of the more interesting areas of research involves using both encapsulated and unencapsulated cells as bio-PEO-modified poly(hydroxyethyl methacrylate-co-methyl methacrylate) membranes utilized extensively in cellular logical systems for delivery of growth factors. Encapsulated cells have been used to deliver NGF, CNTF, NT4/ microencapsulation (25) .
5, and GDNF, but only the long-term effects of NGF LONG-TERM PRODUCT SYNTHESIS
have been examined. Polymer-encapsulated cells have been reported to survive and continue to secrete NGF Before patients can be routinely implanted with encapsulated cells, long-term survival (>6 months) of the for 13.5 months in normal rodents. Following the 13.5month implant interval, the NGF transgene copy num-encapsulated cells and continued release of the therapeutic molecule must be demonstrated. Although effective ber, as measured with PCR analyses, from the recovered NGF cells was equivalent to preimplant levels, indicat-immunoisolation should result in long-term survival of encapsulated cells, surprisingly few studies have exam-ing NGF gene stability. Additionally, as measured by ELISA, the NGF released from encapsulated cells into ined long-term (>3 months) implant viability. A few notable exceptions exist and provide compelling evidence the tissue culture medium was 64% higher following removal from the rat lateral ventricles after the 13.5-month about the potential for long-term survival and release of molecules from the cells. Encapsulated PC12 cells se-interval in situ (111) . No deleterious effects from NGF were detectable on body weight, mortality rate, motor/ crete high levels of catecholamines under both basal and evoked conditions and have been evaluated as a poten-ambulatory function, or cognitive function as assessed with the Morris water maze and delayed matching to tial means of delivering dopamine to the striatum of Parkinson's disease patients. Following encapsulation, position in healthy young adult rats. In addition, there was no evidence that NGF from these encapsulated cells PC12 cells have been maintained in vitro and in vivo for at least 6 months, while maintaining a typical mor-produced hyperalgesia, although tests of somatosensory thresholds did reveal effects related to the NGF delivery. phology and clustered arrangement along the lumen of the device (2, 3, 62, 98) . The cells remain tyrosine hydrox-Morphologic analysis of retrieved cell-loaded devices revealed abundant viable BHK-NGF cells throughout ylase (TH) immunoreactive and can be seen in various stages of mitosis, with some necrosis in regions of high the capsule. These same animals exhibited a marked hypertrophy of cholinergic neurons within the striatum and cell density. The continued presence of TH suggests that the encapsulated cells maintain the ability to synthesize nucleus basalis as well as a robust sprouting of cholinergic fibers within the frontal cortex and lateral septum and release dopamine, and indeed spontaneous and evoked release of dopamine can be detected from cap-proximal to the implant site. Although no deleterious behavioral effects were observed, the profound anatomi-sules maintained both in vitro and following explanta-cal changes and their relationship to functional alter-a Morris water maze (Fig. 5 ). Cognitive function, as measured in this task, declined with age. Evidence of ations in normal and diseased brain warrant additional study.
age-related atrophy of cholinergic neurons was observed in the striatum, medial septum, nucleus basalis, and ver-ENCAPSULATED NGF-PRODUCING tical limb of the diagonal band. These anatomical CELLS IN ANIMALS MODELS OF changes were most severe in animals with the greatest ALZHEIMER'S DISEASE cognitive impairments, suggesting a link between the Alzheimer's disease (AD) affects approximately 5% two pathological processes. Following training, animals of the population over the age of 65 and is the most received bilateral intraventricular implants of encapsuprevalent form of adult-onset dementia. With the inlated NGF or control cells. The 18-and 24-month-old crease in our aging population, the incidence of AD is animals receiving NGF cells showed a significant imexpected to triple over the next 75 years. The most provement in cognitive function (Fig. 5) . No improveprominent feature of AD is a progressive deterioration ments or deleterious effects were observed in the young, of cognitive and mnemonic ability, which is at least parnonimpaired animals. Anatomically, the NGF released tially related to the degeneration of basal forebrain from the encapsulated cells increased the size of the atcholinergic neurons. At present, treatments are ineffecrophied basal forebrain and striatal cholinergic neurons tive for either slowing or preventing cholinergic neuron to the size of the neurons in the young, healthy rats. loss or the associated memory deficits. Several converg-Furthermore, there was no evidence that the NGF cells ing lines of evidence indicate that NGF has potent tarproduced changes in mortality, body weights, somatoget-derived trophic and tropic effects upon cholinergic sensory thresholds, potential hyperalgesia, or activity basal forebrain neurons (7,46,47,54-59,65,72,76,86,87, levels, suggesting that the levels of NGF produced were 92,100-102).
neither toxic nor harmful to the aged rats.
Primate Studies Rodent Studies
Although no model faithfully recaptitulates the com-Similar results were obtained in nonhuman primates, an essential prerequisite to human clinical trials. In these plex etiology and time-dependent loss of cholinergic neurons seen in AD patients, model systems have been studies, cynomolgus primates received transections of the fornix followed by placement of encapsulated NGF developed to answer the specific question: Can NGF prevent the death of damaged cholinergic neurons fol-or control cells into the lateral ventricle ( Fig. 6 ). In the control animals, a significant reduction the number of lowing acute trauma? Initial studies determined whether encapsulated BHK cells modified to produce human cholinergic neurons was observed in the medial septum and vertical limb of the diagonal band of Broca. Again, NGF could prevent cholinergic neuron loss following aspiration of the fimbria/fornix (109) . Rats received le-loss of cholinergic neurons was prevented by implants of NGF-secreting cells. It also appeared that cholinergic sions of the fimbria/fornix followed by intraventricular implants of either NGF-producing or control (non-neurons within the medial septum of NGF-treated animals were larger, more intensely labeled, and elaborated transfected) cells. Control-implanted animals had an extensive loss of ChAT-positive cholinergic neurons ipsi-more extensive proximal dendrites than those displayed by BHK control animals (Fig. 7) . lateral to the lesion that was prevented by NGF cell implants. Quantitation of ChAT-positive neurons for the In addition to the effects on cell viability, NGF implants induced a robust sprouting of cholinergic fibers two groups revealed that with the control capsules, 14% of the neurons remained viable on the lesioned side proximal to the implant site (33) . All monkeys receiving NGF implants displayed dense collections of NGF re-compared with the nonlesioned side, whereas with the NGF capsules, 88% of the cholinergic neurons were res-ceptor-immunoreative fibers throughout the entire dorsoventral extent of the lateral septum. This effect was cued.
One of the cardinal behavioral symptoms of AD is a unilateral as the contralateral side displayed only a few cholinergic fibers in a manner similar to that seen in progressive loss of cognitive ability. Just as no animal model faithfully mimics the complex etiology and patho-control-implanted monkeys. The cholinergic nature of this sprouting was confirmed by an identical pattern of physiology of AD, comparable behavioral abnormalities are difficult to reproduce in animal models. However, fibers, which were both ChAT immunoreactive and AChE positive. These fibers ramified against the epen-the aged rodent shows a progressive degeneration of basal forebrain cholinergic neurons together with dymal lining of the lateral ventricle adjacent to the transplant site and were particularly prominent within the marked cognitive impairments that are partly reversible by administering NGF. Lindner et al. (69) trained 3-, dorsolateral quadrant of the septum corresponding to the normal course of the fornix. The cell sparing and sprout-18-, and 24-month-old rats on a spatial learning task in treatment that effectively addresses the behavioral symptoms or slows the inexorable neural degeneration in HD.
Intrastriatal injections of excitotoxins such as quinolinic acid (QA) have become a useful model of HD and can serve to evaluate novel therapeutic strategies aimed at preventing, attenuating, or reversing neuroanatomical and behavioral changes associated with HD (8-10,84). The use of trophic factors in a neural protection strategy may be particularly relevant for the treatment of HD. Unlike other neurodegenerative diseases, genetic screening can identify virtually all individuals at risk who will ultimately suffer from HD. This provides a unique opportunity to design treatment strategies to intervene prior to the onset of striatal degeneration. Thus, instead of replacing neuronal systems, which have already undergone extensive neuronal death, trophic factor strategies could be designed to support host systems destined to die at later time in the patient's life.
Rodent Studies
Infusions of trophic factors such as NGF or implants of cells genetically modified to secrete NGF have proven effective in preventing the neuropathological sequelae resulting from intrastriatal injections of excitotoxins, including QA (41-43,85). Emerich and colleagues (32, 34, 63) examined the ability of encapsulated trophic fac- striatum. An analysis of Nissl-stained sections demonstrated that the size of the lesion was significantly reduced in those animals receiving NGF and CNTF cells compared with those animals receiving control implants. ing results have been replicated in a group of aged, non-Moreover, both NGF and CNTF cells attenuated the exhuman primates (61) . tent of host neural damage produced by QA as assessed POLYMER-ENCAPSULATED by a sparing of specific populations of striatal cells, in-CELLS TO DELIVER NEUROTROPHIC cluding cholinergic, diaphorase-positive, and GABAer-FACTORS IN ANIMAL MODELS OF gic neurons (Fig. 8 ). Neurochemical analyses have con-HUNTINGTON'S DISEASE firmed the protection of multiple striatal cell populations using this strategy ( Table 2 ). These results suggested Huntington's disease (HD) is an inherited, progressive neurological disorder characterized by a severe that implantation of polymer-encapsulated trophic factor-releasing cells can protect neurons from excitotoxin degeneration of basal ganglia neurons, particularly the intrinsic neurons of the striatum. Accompanying the damage. Importantly, behavioral studies offer additional and compelling evidence of neuronal protection that can pathological changes is a progressive dementia coupled with uncontrollable movements and abnormal postures.
be produced in animal models of HD (Table 3) . Trophic factor-secreting cells have provided extensive behavioral From the time of onset, an intractable course of mental deterioration and progressive motor abnormalities be-protection as measured by tests that assess both gross and subtle movement abnormalities. Moreover, these gins with death usually occurring within 15-17 years. Overall, the prevalence rate of HD in the U.S. is approx-same animals show improved performance on learning and memory tasks, indicating the anatomical protection imately 50 per 1,000,000 (30) . At present there is no afforded by trophic factors in this model is paralleled by the rodent studies, the volume of striatal damage was decreased, and both GABAergic and cholinergic neu-a robust and relevant behavioral protection.
rons destined to degenerate were spared in CNTF-Primate Studies grafted animals ( Fig. 9 , Table 4 ). Although all animals had significant lesions, there was a three-and sevenfold The ability of cellularly delivered trophic factors to increase in GABAergic neurons in the caudate and putapreserve neurons within the striatum in a rodent model men, respectively, in CNTF-grafted animals relative to of HD led to similar studies in nonhuman primates, a controls. Similarly, there was a 2.5-and fourfold instep that is crucial to the initiation of clinical trials. A crease in cholinergic neurons in the caudate and putaparadigm similar to the one employed in the rodent studmen, respectively, in CNTF-grafted animals. ies was used in nonhuman primates (35). Polymer
The ability to preserve GABAergic neurons in anicapsules containing CNTF-producing cells were grafted mals models of HD is an important, though not entirely into the striatum of rhesus monkeys (Fig. 9 ). One week sufficient, step to develop a useful therapeutic. If the later, a QA injection was placed into the putamen and perikarya are preserved without sustaining their innervacaudate proximal to the capsule implants. As seen in to these grafts, the cells apparently maintain their projections. But are afferents to the striatum, specifically from the cerebral cortex, also influenced by these grafts? This may be particularly critical if some of the more devastat-tion, then the experimental therapeutic strategy under investigation is not likely to yield significant value. The ing nonmotor symptoms seen in HD result from cortical changes secondary to striatal degeneration. Because layer striatum is a central station in series of loop circuits that receive inputs from all of the neocortex, projecting V neurons from motor cortex send a dense projection to the post-commissural putamen, a region that was se-to a number of subcortical sites, and then return information flow to the cerebral cortex. One critical part verely impacted by the QA lesion, the effects of QA lesions and CNTF implants on the number and size of of this circuitry is the GABAergic projections to the globus pallidus and substantia nigra pars reticulata, the cortical neurons in this region were examined. Although the QA lesion did not affect the number of neurons in parts of the direct and indirect basal ganglia loop circuits. One approach to examining the integrity of this this cortical area, layer V neurons were significantly reduced in a cross-sectional area on the side ipsilateral to circuit is to use an antibody that recognizes GABAergic terminals (DARPP-32) to determine if the preservation the lesion in control-grafted monkeys. This atrophy of cortical neurons was virtually completely reversed by of GABAergic somata within the striatum also results in the preservation of the axons of these neurons to critical CNTF grafts (35). While the sparing of striatal neurons and maintenance extrastriatal sites. Using quantitative morphological assessment of DARPP-32 optical density, it has been of intrinsic circuitry is impressive, the magnitude of the effect is less than that seen in rodents. In primates, ro-shown that monkeys receiving QA lesions have significant reductions in DARPP-32 immunoreactivity within bust protection is limited to the area of the capsules. However, the area of the lesion remains extensive and it is likely that diffusion of CNTF from the capsule may 
SUMMARY AND CONCLUSIONS
tional access of nutrients for maintaining cell viablity and biologically active, potentially therapeutic molecules out into the host brain. The membrane also pre-Considerable evidence indicates that neural transplantation ameliorates the behavioral deficits seen in a vents elements of the immune system from destroying cells, allowing transplantation of cells from adult donors number of animal models of neurodegenerative diseases. Recent studies in humans support these preclinical stud-of the same species, or even other species, thereby greatly enhancing the availability of tissue sources for ies and clearly indicate that transplantation of fetal neural tissue shows promise to treat human CNS diseases. transplantation into patients. Animal studies have demonstrated that encapsulated cells survive, continue to re-Despite its promise in animals and humans, human fetal tissue is complicated by a complex of societal and ethi-lease biologically active molecules, and promote functional recovery following implantation into rodent and cal considerations as well as by the ability to obtain adequate amounts of quality-controlled donor tissue. These primate models of CNS diseases. Polymer encapsulated cell implants have the theoretical advantage of being re-considerations have led investigators to search for alternative means of cell transplantation to deliver therapeu-trievable, should the transplant produce undesired effects, or should the cells need to be replaced. Implants tic compounds to the CNS. In this article we have described the available preclinical and initial clinical ex-may also be designed to allow repeated and minimally invasive removal and replacement of cells over time. perience and results with encapsulated cells as one possible means of correcting the behavioral and anatomical
In conclusion, it appears that the implantation of encapsulated cells may provide an effective means of alle-consequences of CNS diseases.
There are several promising results and theoretical viating the symptoms of numerous human conditions/ diseases. One particularly attractive avenue of research advantages for encapsulated cells/tissue. The permselective membranes of the polymeric capsules allow bidirec-continues to be the application of trophic factors to mini- 
